Cargando…
Prevalence of multidrug-resistant tuberculosis among Category II pulmonary tuberculosis patients
BACKGROUND & OBJECTIVES: Multidrug-resistant tuberculosis (MDR-TB) has emerged as a significant global health concern. The most important risk factor for the development of MDR-TB is previous anti-tuberculosis therapy. Category II pulmonary TB includes those patients who had failed previous TB t...
Autores principales: | Sharma, Surendra K., Kumar, Sanjeev, Saha, P.K., George, Ninoo, Arora, S.K., Gupta, Deepak, Singh, Urvashi, Hanif, M., Vashisht, R.P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103157/ https://www.ncbi.nlm.nih.gov/pubmed/21441686 |
Ejemplares similares
-
Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis
por: Sharma, Surendra K., et al.
Publicado: (2011) -
Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial
por: Sharma, Surendra K., et al.
Publicado: (2017) -
Coronin-1 levels in patients with tuberculosis
por: Sinha, Sanjeev, et al.
Publicado: (2021) -
Comparative Evaluation of GenoType MTBDRplus Line Probe Assay with Solid Culture Method in Early Diagnosis of Multidrug Resistant Tuberculosis (MDR-TB) at a Tertiary Care Centre in India
por: Yadav, Raj N., et al.
Publicado: (2013) -
Diagnostic utility of a line probe assay for multidrug resistant-TB in smear-negative pulmonary tuberculosis
por: Singh, Binit Kumar, et al.
Publicado: (2017)